Τα δυο προηγούμενα συνέδρια το 2014 και το 2016 πραγματοποιήθηκαν στην Ελλάδα (Κέρκυρα και Σπάρτη), ενώ τώρα το τρίτο, θα λάβει χώρα στο Τορόντο 25-28 Οκτωβρίου (https://www.genedis.eu/) σε συνεργασία με δύο πανεππιστήμια του Τορόντο και με το Ινστιτούτο Fields.
Καλούνται όλοι οι εκπρόσωποι των ελληνικών ομογενειακών Μέσων Ενημέρωσης, να στηρίξουν με την παρουσία τους, καλύπτοντας δημοσιογραφικά το τόσο σημαντικό συνέδριο κατά την τελετή έναρξης και καθ' όλη τη διάρκειά του.
Ακολουθεί το Δελτίο Τύπου στην αγγλική:
3rd World Congress on Genetics, Geriatrics and Neurodegenerative Diseases Research
25 -28 October 2018, Toronto, Canada
On behalf of Bioinformatics and Human Electrophysiology Laboratory, we are pleased to inform about the 3rd World Congress on "Genetics, Geriatrics and Neurodegenerative Diseases Research" (GeNeDis 2018) which will be held in Toronto Canada, from 25 to 28 of October 2018 (www.genedis.eu).
For the third time three of the most modern and popular scientific areas are brought together in a congress, the 3rd World Congress on Genetics, Geriatrics and Neurodegenerative Disease research with the title: “Health Aging and Mental Wellness in the new digital era” Leading scientists and researchers from all over the world will discuss the recent developments in these disciplines, ranging from research progress and the latest scientific discoveries to the clinical and pharmaceutical applications.
GeNeDis 2018 will focus on a strong scientific program combined with teaching, training and live workshops to inform and educate scientist on the latest major challenges in scientific research, the new drug targets, the development of novel biomarkers, the new imaging techniques and the novel protocols for early diagnosis of neurodegenerative diseases, and several other scientific advances. GeNeDis 2018 will feature an internationally recognized widely diverse program, that will contribute in attracting delegates to attend this major event.
The goal of the 3rd World Congress GeNeDis 2018 is to strengthen and broaden the international network by sharing the recent advancements in Genetics, Geriatrics and Neuroscience and by establishing good contacts with all relevant stakeholders – all pursuing the excellence in research, development, education and training with the aim of better and safe health aging.
The conference is organized by the Bioinformatics and Human Electrophysiology Laboratory, (BiHELab), Department of Informatics, Ionian University, Greece, in collaboration with CARGO lab at Wilfrid Laurier University, Ontario, Canada. The Scientific Organizing committee consists of experts from several countries who understand the educational and information business needs of scientists in the research area.
Topics of interest
Geriatrics, Neurodegenerative Diseases, Sleeping disorders, Neuroimaging, Clinical neurophysiology, Clinical genetics and genomics, System Biology, Genome engineering, Computational biology, Big data and genome medicine, Diagnostic of human disease biomarkers, Gene expression analysis, Neuropharmacology, Pharmacogenomics, Diagnostic protocols and tests, Nanotechnology, Quality of life and healthcare.
The conference proceedings will be published by Springer in the well-known Series: Advances in Experimental Medicine and Biology (AEMB), I.F.: 1.825.
*The organizers will offer 100 places for young researchers/participants free of charge (please contact: email@example.com)
- Bioinformatics and Human Electrophysiology Laboratory, (BiHELab), Department of Informatics, Ionian University, Greece.
- CARGO lab, Wilfrid Laurier University, Waterloo, Ontario, Canada
- Fields Institute for research in mathematical sciences
- GryPHone Lab, Ontario, Canada
Research at the BiHELab focuses on fundamental questions in geriatrics and neurodegeneration. Exploiting the power of a range of model organisms and the latest molecular, imaging and electrophysiological and computational technologies in neuroscience, BiHELab scientists explore some of the key processes underlying neuronal function and behavior. Faculty research interests are relevant for understanding neurological diseases including Alzheimer’s, Parkinson’s, ALS, autism-spectrum disorders, depression, anxiety, epilepsy and insomnias. BiHELab is tracing new biomarkers concerning neurodegenerative diseases and constructs frailty functions depending on them. Last year a new Research Center entitled ‘Research Center on Computational Biomarkers (RCCBM)’ was set on Wilfrid Laurier University’s Waterloo campus by the Directors of the CARGO Lab and BiHELab focusing on studying human biomarkers and aiming of providing precision medicine based on personalized measurements of specific biomarkers ( http://www.rccbm.org/). Besides, BiHELab became the first Greek laboratory- academic partner of HLF Heidelberg (http://www.heidelberg-laureate-forum.org/)